Article Text

Download PDFPDF

Plant-based diet and COVID-19 severity: results from a cross-sectional study
  1. Samira Soltanieh1,
  2. Marieh Salavatizadeh1,
  3. Tooba Ghazanfari2,
  4. Soodeh Razeghi Jahromi1,
  5. Zahra Yari1,
  6. Mohammad Ali Mansournia3,
  7. Maryam Nazemipour3,
  8. Jalil Arab Kheradmand4,
  9. Sussan K Ardestani5,
  10. Sara Karimi1 and
  11. Azita Hekmatdoost1
  1. 1Department of Clinical Nutrition and Dietetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  2. 2Immunoregulation Research Center, Shahed University, Tehran, Iran (the Islamic Republic of)
  3. 3Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  4. 4Ahya Neuroscience Research Center, Tehran, Iran (the Islamic Republic of)
  5. 5Department of Immunology, University of Tehran, Tehran, Iran (the Islamic Republic of)
  1. Correspondence to Dr Azita Hekmatdoost, Department of Clinical Nutrition and Dietetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran (the Islamic Republic of); a_hekmat2000{at}


Although previous findings have shown the beneficial role of healthy eating pattern on the human immune system, the association between plant-based diet and COVID-19 severity has not yet been elucidated. This study aimed to determine the possible role of plant-based diet index (PDI) in COVID-19 severity. This cross-sectional, multicentral study was conducted on 141 patients with confirmed COVID-19. Dietary intakes of the patients were evaluated using a validated food frequency questionnaire. Then, PDI was compared between patients who needed to be hospitalised (considered severe cases), and those who got treatment at home (considered non-severe cases). After adjustment for confounders including age, sex, energy intake and body mass index, lower odds of hospitalisation were found for participants having a greater score of overall PDI (OR per 10 units increase: 0.42; 95% CI 0.22 to 0.80) and healthy PDI (OR per 10 unit increase: 0.45; 95% CI 0.26 to 0.78). In conclusion, our data presented that there is a relation between PDI and lower risk of hospitalisation in COVID-19 patients, possibly through boosting the immune function.

  • COVID-19
  • Dietary patterns

Data availability statement

Data are available on reasonable request.

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The beneficial role of healthy eating pattern on the human immune system has been shown previously.


  • Our data presented that there is a relation between plant-based diet index and lower risk of hospitalisation in COVID-19 patients, possibly through boosting the immune function.


  • These findings indicate that following a plant-based diet can ameliorate COVID-19 disease symptoms and signs.


COVID-19 pandemic has exerted an outsize influence on people’s lifestyles, food choices, food security and food access in different groups of society all over the world.1 Nutritional factors are known as a key element affecting immunity, risk of infection and mortality. The impact of adaptable risk factors such as diet, exercise, healthy lifestyle on regulation of inflammatory mediators to lower the risk of infection is well documented.2 On the contrary, leading unhealthy lifestyle (including exacerbating dietary patterns and inactivity) is considered to be linked with an increased level of oxidative stress being conducive to progression of non-communicable diseases.3 4 Experimental researches and studies lend evidence to the fact that a myriad of vitamins (A, B6, B12, folate, C, D and E) and trace elements (zinc, copper, selenium, iron) play a crucial role in supporting immune system against bacteria and viruses.5 Taking healthy eating measures which is consistent with consumption of a diverse diet, various plant-based and animal-based foods have a profound impact on boosting immune defence.6 Many infectious diseases stem from gut dysbiosis that results in an uncontrolled excessive inflammatory responses that can worsen COVID-19.7 Healthy dietary patterns, many plant foods, fibres and fermented foods can modify and maintain gut microbiota for further immune supply against infections, including of the respiratory tract.6 Kim et al conducted a case–control study on 568 COVID-19 cases (138 moderate-to-severe cases, 430 very mild to mild COVID-19 severity) and 2316 controls. Their findings reported that individuals who followed ‘plant-based diets’ had 73% (OR 0.27, 95% CI 0.10 to 0.81) lower odds of moderate-to-severe COVID-19 severity as opposed to participants who did not follow this diet.8 Plant-based diets are rich in whole grains, legumes, vegetables, potato, fruits, seeds and low in meat consumption.9 The plant foods are great sources of protease inhibitors like trypsin and trypsin-chymotrypsin inhibitors, which are bioavailable and are able to prevent SARS-CoV-2 from binding to the host cells.10

To the best of our knowledge, there is no published study regarding the association of plant-based diet index (PDI) and COVID-19 severity. The purpose of this study is to investigate whether plant-based diets using PDI might be useful to alleviate COVID-19 severity and prevent patients from getting hospitalised. Although clinical studies on this matter are scarce, there is evidence from previous prepandemic epidemiological, observational and clinical studies that demonstrates the benefits of plant-based diets on some conditions that can also be found in individuals with COVID-19.

Materials and methods

Study population

This cross-sectional study was conducted on 141 individuals (75 men, 66 women) with the mean age of 46.23 years. Inpatient participants were collected from Imam Khomeini hospital, Tehran, Iran, and outpatients were recruited from Simorgh clinical laboratory. The details of sampling were presented previously.11 Individuals with ascertained COVID-19 infection by a specialist were opted for the research. Participants with history of diabetes, hypertension, kidney disease, cancer, and cardiovascular diseases, consuming nutritional supplements, and/or some special diets in the last year, any alternations in the dose and type of one’s medicine, pregnancy and lactation, and unwilling or unable to cooperate were excluded from the study. Informed consent was obtained from all participants. People who met the criteria were divided into two groups: (1) severe cases included patients who needed hospitalisation except for the ICU unit, required non-invasive breathing support or administration of antibiotics combined with oxygen support and (2) non-severe cases included patients treated as outpatients in what is mentioned as home-hospitalisation. Demographic, clinical and laboratory data were included from the study entitled ‘Immunological aspects of COVID-19 in selected provinces of Iran’,11 approved by ‘National institute for medical research development’ (IR.NIMAD.REC.1399.041).

Dietary assessment

Assessment of dietary intakes of participants was done using a valid and reliable semiquantitative food frequency questionnaire containing 147 food items.12 Individuals were asked to report their frequency of intake of each food item during the past year daily, weekly or monthly by Trained researchers via telephone interview. The reported portion sizes were converted to daily intakes. Using Nutritionist IV software (V.7.0; N-Squared Computing) adapted for Iranian foods, the nutrient content of each food item was calculated.

Plant-based diet indices

Total PDI and healthful PDI (hPDI) were calculated by means of previous methods.13–15 Eighteen food groups were created and divided into three main groups: healthy, unhealthy foods and animal foods. Healthy food groups involve whole grains, fruits, vegetables, legumes, vegetable oils, nuts, tea and coffee whereas less healthy food groups include sugar-sweetened beverages, refined grains, fruit juices, potatoes, sweets and desserts. Animal food groups comprised animal fats, dairy products, eggs, fish and sea foods, poultry and red meat, and miscellaneous animal-based foods. Table 1 shows the details of food grouping. For each food group, the quintile of consumption was applied and a score of 1 to 5 was regarded to it. For PDI, the scores of 5 and 1 were given to the first and last quintiles of plant food intake, respectively. Furthermore, the participants consuming the highest and lowest quintiles of animal foods received scores of 1 and 5, respectively. Moreover, the scores of 5 and 1 were applied for the highest and lowest quintile of healthy plant foods in order to calculate hPDI, respectively. A score of 1 was an indicator of highest consumption while the score of 5 indicated the lowest intake of unhealthy plant foods and animal food items. Scores were added up so as to calculate PDI and hPDI indexes ranging from 18 to 90. Higher total score for each index was related to higher adherence to it.

Table 1

Categorisation of food items comprising 18 food groups for computing plant-based diet Indices (PDI)

Assessment of other variables

A digital scale (Seca 808, Germany) with an accuracy of 0.1 kg was used to measure weight while participants were with light clothes and unshod. To measure height, unshod, a wallmounted stadiometer with a sensitivity of 0.1 cm (Seca, Germany) was applied. Body mass index (BMI) was computed through dividing weight (in kg) by height (in m2). Biomedical factors including white cell count, interleukin-6, C reactive protein, lymphocytes, neutrophils and neutrophil to lymphocyte ratio were collected from individuals’ medical files.

Statistical analysis

The quantitative variables were described using mean (SD) or median (IQR), separately in the tertiles of the variables healthy and total. Linear regression was used to test if the mean of quantitative variables were different over the tertiles; bootstrapping and robust SEs were used if needed.16 A χ2 test was used for comparison of categorical variables. Multivariable logistic regression was used to estimate the adjusted ORs per 10 units increase with 95% CIs between the exposure variables hPDI and total PDI with the outcome hospitalisation. The confounders, age, sex, BMI and energy intake were identified from the literature and adjusted for in the analysis. The linearity assumption for the exposure and quantitative confounders was assessed using fractional polynomials.17 18 Values of p<0.05 were considered significant.


General characteristics of participants across tertiles of total PDI and hPDI are presented in table 2. There was no strong evidence against no differences between categories of total PDI and hPDI scores in terms of age, sex, weight, BMI and laboratory markers.

Table 2

General characteristics of participants according to tertiles of healthy plant-based diet index (hPDI) and total PDI*

Table 3 indicates multivariable-adjusted OR estimates with 95% CIs, and p values for COVID-19 hospitalisation according to total PDI and hPDI. Fractional polynomials confirmed linearity assumption for both exposures and quantitative confounders. In the crude model, when total PDI and hPDI scores increased by 10 units, the odds of COVID-19 hospitalisation significantly diminished by 10% and 9%, respectively. However, after adjustment for confounders including age, sex, energy intake and BMI, the odds of COVID-19 hospitalisation declined by 58% per 10 units increase in total PDI (OR 0.42; 95% CI 0.22 to 0.80). Each 10 units higher score of hPDI resulted in 55% lower odds of hospitalisation (OR 0.45; 95% CI 0.26 to 0.78).

Table 3

Multivariable-adjusted* OR estimates with 95% CIs and p values between total PDI and hPDI with COVID-19 hospitalisation


Although it has been shown that healthy eating pattern has an essential role in boosting the human immune system,6 the relationship between PDI and the risk of COVID severity has not yet been elucidated. This study was conducted to evaluate whether plant-based diets are useful to alleviate COVID-19 severity.

In this study, a significant association was observed between PDI and the reduced risk of COVID-19 severity after controlling potential confounders. Based on the findings of the current study, higher scores of PDI were significantly related with a decreased odds of COVID-19 hospitalisation by 59% within fully adjusted model for potential confounders. In other words, we observed that patients in the last tertile of PDI and hPDI had less risk of being hospitalised in comparison to those in the lowest tertile. Our findings are aligned with preliminary evidence showing that the burden of infectious diseases could be reduced by improving nutrition.6 19–21 Our findings also concur with the study (Prevencion con ‘Dieta Mediterranea) in which adherence to plant-rich dietary patterns was inversely associated with all-cause mortality.13 A review of studies, although scarce, indicates the general benefits of plant-based diet in diminishing the burden of COVID-19.22 In accordance with our finding, Merino et al revealed that healthy plant-based foods could decrease the risk and severity of COVID-19.21 In this large survey, it was shown that as the quality of the diet rises, the risk of disease COVID-19 (HR 0.91) and severe COVID-19 (HR 0.59) diminishes. This association was more pronounced among patients with lower socioeconomic status. Our results could expand previous individual nutrient examinations and highlight the beneficial association of healthy dietary patterns.23 24

According to a recent population-based case and control study in six countries, there were significant inverse associations between plant-based diets or pescatarian diets with the odds of moderate-to-severe COVID-19.8 Researchers in the study also found that following plant-based diets could protect subjects against severe COVID-19. In this survey, COVID-19 cases and controls completed a web-based questionnaire about demographic characteristics, dietary information and COVID-19 outcomes. The results of this study showed that participants following a plant-based diet had a 73% lower risk of moderate-to-severe COVID-19.

There are several mechanisms involved in lowering the risk of COVID-19 hospitalisation following healthful plant-based diet. One of the possible explanations for the positive correlation between PDI and reducing the risk of hospitalisation due to COVID-19 in this study is the support of the immune system following a healthy diet.6 25 Moreover, great amounts of nutrients including phytochemicals, fibre, antioxidants, unsaturated fatty acids, vitamins A, C and E, folate, and mineral are found in plant-based diets.26 27 It has been proven that these nutrients could improve the immune system by means of increasing antibody production, proliferation of lymphocytes and reduction of oxidative stress.6 28 Reduced risk of respiratory infections including common colds, influenza and pneumonia, as well as reduced severity and duration of illness following supplementation of some of these nutrients, specifically, vitamins A, C, D and E have been reported.6 29–32

This study had some limitations. Although we adjusted our analysis for several confounders, some confounders such as physical activity, socioeconomic status and serum vitamin D were not assessed. The inability to confirm a causal relationship between PDI and COVID-severity was another limitation, like any other observational study.


All in all, following a plant-based diet, could be effective in preventing COVID-19 severity. The findings of this study support our hypothesis that the higher the PDI, the lower the chance of hospitalisation in patients with COVID-19. Future prospective studies are warranted to confirm our findings.

Data availability statement

Data are available on reasonable request.

Ethics statements

Patient consent for publication

Ethics approval

The study protocol was also approved by the Ethical Committee of National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences (IR.SBMU.NNFTRI.REC.1399.046). This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Ethical Committee of National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences (IR.SBMU.NNFTRI.REC.1399.046). Written informed consent was obtained from all subjects/patients.


This study was funded by Shahid Beheshti University of Medical Sciences with grant number of 24816.



  • Contributors SS, MS and AH designed this study. SS and MS wrote the manuscript, and participated in data acquisition. TG and SK conducted data acquisition. SRJ and TG revised the manuscript. ZY and AH wrote the manuscript. MAM and MN were responsible for analysis, and interpretation of data. JAK and SKA edited the manuscript. AH is responsible for the overall content as the guarantor. All authors read and approved the final manuscript.

  • Funding This research was supported by Shahid Beheshti University of Medical Sciences with grant number of 24816.

  • Competing interests No, there are no competing interests.

  • Provenance and peer review Not commissioned; externally peer reviewed by Dr. Atoosa Saidpour, SBUMS46, West Arghavan St., Farahza Tehran Iran, United Kingdom of Great Britain and Northern Ireland.